C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01) A61K 31/70 (2006.01) C07H 21/00 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2300352
Disclosed are synthetic oligonucleotides having a nucleotide sequence specifically complementary to nucleotides 324 to 345 of a conserved gag region of the HIV-1 genome, the oligonucleotide consisting of 21 nucleotides which are linked via phosphorothioate internucleotide linkages. Also disclosed are methods for inhibiting and treating HIV-1 and HIV-2 infection.
L'invention concerne des oligonucléotides synthétiques présentant une séquence nucléotidique spécifiquement complémentaire des nucléotides 324 à 345 de la région gag conservée du génome du VIH-1, l'oligonucléotide se composant de 21 nucléotides lesquels sont liés par des liaisons internucléotidiques phosphorothioate. L'invention concerne également des méthodes d'inhibition et de traitement d'infections à VIH-1 et VIH-2.
Hybridon Inc.
Smart & Biggar
LandOfFree
Novel hiv-specific synthetic oligonucleotides and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel hiv-specific synthetic oligonucleotides and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel hiv-specific synthetic oligonucleotides and methods of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1732623